Center for Financial Planning’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.3K | Sell |
50
-17
| -25% | -$7.57K | ﹤0.01% | 384 |
|
|
2025
Q1 | $32.5K | Hold |
67
| – | – | ﹤0.01% | 335 |
|
|
2024
Q4 | $27K | Buy |
67
+17
| +34% | +$6.85K | ﹤0.01% | 319 |
|
|
2024
Q3 | $23.3K | Hold |
50
| – | – | ﹤0.01% | 323 |
|
|
2024
Q2 | $23.4K | Hold |
50
| – | – | ﹤0.01% | 307 |
|
|
2024
Q1 | $20.9K | Buy |
+50
| New | +$20.9K | ﹤0.01% | 322 |
|
|
2021
Q2 | – | Sell |
-59
| Closed | -$13K | – | 545 |
|
|
2021
Q1 | $13K | Hold |
59
| – | – | ﹤0.01% | 358 |
|
|
2020
Q4 | $14K | Sell |
59
-50
| -46% | -$11.9K | ﹤0.01% | 315 |
|
|
2020
Q3 | $30K | Sell |
109
-50
| -31% | -$13.8K | 0.01% | 225 |
|
|
2020
Q2 | $46K | Buy |
159
+100
| +169% | +$28.9K | 0.02% | 192 |
|
|
2020
Q1 | $14K | Hold |
59
| – | – | ﹤0.01% | 292 |
|
|
2019
Q4 | $13K | Buy |
+59
| New | +$13K | ﹤0.01% | 292 |
|